US Representative

Celeste Maloy 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 2)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3049

Introduced
5/2/23  
Refer
5/2/23  
Refer
5/22/23  
Utah School and Institutional Trust Lands Administration Exchange Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3269

Introduced
5/11/23  
Refer
5/11/23  
Report Pass
4/17/24  
Law Enforcement Innovate to De-Escalate Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3396

Introduced
5/17/23  
Refer
5/17/23  
Refer
5/22/23  
Refer
6/23/23  
Fire Department Repayment Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3397

Introduced
5/17/23  
Refer
5/17/23  
Report Pass
6/21/23  
Western Economic Security Today Act of 2024 WEST Act of 2024
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3497

Introduced
5/18/23  
Uranium Miners and Workers Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4094

Introduced
6/14/23  
Refer
6/14/23  
Refer
7/21/23  
Report Pass
11/15/23  
Great Salt Lake Stewardship Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB427

Introduced
1/20/23  
Refer
1/20/23  
Support And Value Expectant Moms and Babies Act of 2023 or the SAVE Moms and Babies Act of 2023 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4310

Introduced
6/22/23  
Refer
6/22/23  
Refer
6/23/23  
Report Pass
12/6/23  
Youth Poisoning Protection Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4438

Introduced
6/30/23  
Refer
6/30/23  
John W. Walsh Alpha-1 Home Infusion Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4577

Introduced
7/12/23  
Refer
7/12/23  
Protecting U.S. Farmland and Sensitive Sites From Foreign Adversaries Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4721

Introduced
7/18/23  
Main Street Tax Certainty Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB5012

Introduced
7/27/23  
Refer
7/27/23  
Refer
7/28/23  
SHINE for Autumn Act of 2023 Stillbirth Health Improvement and Education for Autumn Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB5030

Introduced
7/27/23  
Refer
7/27/23  
Secure Rural Schools Reauthorization Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB5089

Introduced
7/28/23  
Refer
7/28/23  
Refer
7/31/23  
Refer
9/19/23  
Reducing Regulatory Burdens Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB5099

Introduced
8/1/23  
Refer
8/1/23  
Dairy Nutrition Incentive Program Act of 2023